Xiaobin L. Zheng
Fuzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications
Expert consensus on cancer treatment-related lung injury.
Journal: Journal of thoracic disease
Published: February 12, 2025
Prognostic Value of Surgical Resection for Non-small-cell Lung Cancer Patients Comorbid With Minimal Pleural Effusion.
Journal: Cancer control : journal of the Moffitt Cancer Center
Published: January 06, 2025
Pretreatment pulmonary tumor necrosis is a promising prognostic imaging biomarker for first-line anti-PD-1/PD-L1 therapy in advanced lung squamous cell carcinoma: a multi-institutional, propensity score-matching cohort analysis.
Journal: Therapeutic advances in medical oncology
Published: December 12, 2023
Rechallenge of immune checkpoint inhibitors in advanced non-small cell lung cancer.
Journal: Thoracic cancer
Published: November 27, 2023
Clinical definition of secondary resistance to immunotherapy in non-small cell lung cancer.
Journal: Thoracic cancer
Published: October 25, 2023
Cerebrospinal fluid circulating tumor DNA contributes to the detection and characterization of leptomeningeal metastasis in non-small cell lung cancer.
Journal: Journal of neuro-oncology
Published: October 19, 2023
Effects of intrathecal pemetrexed on the survival of patients with leptomeningeal metastasis from lung adenocarcinoma: a propensity score matching analysis.
Journal: Journal of neuro-oncology
Published: September 28, 2023
Chemotherapy versus personalized therapy for EGFR mutant lung adenocarcinoma resistance to EGFR-tyrosine kinase inhibitors: a retrospective dual-center study.
Journal: BMC pulmonary medicine
Published: September 10, 2023
Genomic characterisation of de novo EGFR copy number gain and its impact on the efficacy of first-line EGFR-tyrosine kinase inhibitors for EGFR mutated non-small cell lung cancer.
Journal: European journal of cancer (Oxford, England : 1990)
Published: February 05, 2023
Last Updated: 09/26/2026